WHO ICTRP trial

A comparison of Oxytocin and Carbetocin for the prevention of postpartum…

CTRI/2023/03/050426 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2023/03/050426
Public title A comparison of Oxytocin and Carbetocin for the prevention of postpartum haemorrhage in high risk patients undergoing cesarean delivery
Scientific title A comparison of Oxytocin and Carbetocin for the prevention of postpartum haemorrhage in high risk patients undergoing cesarean delivery
Primary sponsor PDU Govt Medical College Rajkot
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Interventions Intervention1: Carbetocin: Carbetocin 100 mcg single i.v. bolus would be given over 1 minute on delivery of the foetus and the clamping of the umbilical cord. Control Intervention1: Oxytocin: Oxytocin 20IU in 1000ml NaCl(0.9%) @ 150ml/hr…
Registration date Jul 3, 2023
Target size 70
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations